A research team has discovered intricate molecular mechanisms driving the RNA processing defects that lead to Huntington's disease and link HD with other neurodegenerative disorders such as ...
News Medical on MSN1d
Researchers uncover molecular mechanisms driving RNA processing defects in Huntington's diseaseA University of California, Irvine-led research team has discovered intricate molecular mechanisms driving the RNA processing defects that lead to Huntington's disease and link HD with other ...
The number of ALS cases in the U.S. is expected to increase by over 10% by 2030, as compared with 2022 prevalence rates, per ...
A University of California, Irvine-led research team has discovered intricate molecular mechanisms driving the RNA processing ...
Amyotrophic lateral sclerosis (ALS) is a rare neurological disorder that affects specific nerve cells in the spinal cord known as motor neurons. Symptoms involve issues with swallowing and speech ...
Amyotrophic lateral sclerosis (ALS) is sporadic in over 90% cases. Its pathogenesis remains largely elusive and the basic remedy for this disease is not established so far. In this CREST project we ...
Announcing a new publication for Acta Materia Medica journal. Complex biological mechanisms and unidentified therapeutic targets for amyotrophic lateral sclerosis (ALS) significantly hinder the develo ...
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...
French-based MaaT Pharma is eyeing up a Phase II study of its immune system modulator after its Phase Ib trial in patients with amyotrophic lateral sclerosis ... in the pathogenesis and ...
People who died with sporadic Creutzfeldt-Jakob disease were more likely to have been prescribed antidepressants before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback